New position created to support growth at MDS Nordion
OTTAWA, Feb. 5 /CNW/ - MDS Nordion, a leading provider of medical
isotopes and radiopharmaceuticals, has appointed Dr. Peter Covitz to the newly
created position of Senior Vice-President Innovation. Dr. Covitz will lead the
global effort for developing and implementing new technology strategies and
identifying new complimentary business opportunities to better serve customers
and support growth at MDS Nordion.
"This new role demonstrates the value we place on engaging creative and
dynamic thinkers and I'm thrilled Dr. Covitz is joining our team," said Steve
West, President, MDS Nordion. "Acting as the primary scientific liaison,
Dr. Covitz will advance our global innovation programs by identifying
opportunities, setting up collaborations, and driving ideas to
Dr. Covitz will report directly to Steve West, President of MDS Nordion
and will be a member of the MDS Nordion Executive Management Team and a
representative on the MDS Scientific Advisory Board.
Dr. Covitz comes to MDS Nordion from the National Cancer Institute (NCI)
in Maryland, United States, where he held the position of Chief Operating
Officer at the NCI's Center for Biomedical Informatics and Information
Technology. He holds a Ph.D in Microbiology from Columbia University and a
B.A. with a major in biology from Colgate University. Dr. Covitz holds a
number of patents and is widely published in scientific journals.
About MDS Nordion
MDS Nordion (www.mdsnordion.com) is a world leader in medical isotopes,
radiation and related technologies. It is a business unit of MDS Inc.
(TSX:MDS)(NYSE: MDZ). MDS is a global life sciences company that provides
market-leading products and services our customers need for the development of
drugs and diagnosis and treatment of disease. We are a leading global provider
of pharmaceutical contract research, medical isotopes for molecular imaging,
radiotherapeutics, and analytical instruments. MDS Inc. has more than 5,500
highly skilled people in 29 countries. Find out more at www.mdsinc.com or by
calling 1-888-MDS-7222, 24 hours a day.
For further information:
For further information: Media: Tamra Benjamin, Director Marketing and
External Communications, MDS Nordion, (613) 592-3400 ext. 1022,
firstname.lastname@example.org; Investors: Sharon Mathers, Senior Vice-President,
Investor Relations and External Communications, MDS Inc., (416) 675-6777 x